From Surf Wiki (app.surf) — the open knowledge base

Dexamethasone suppression test

Medical test

Field	Value
purpose	assess adrenal gland function
Name	Dexamethasone suppression test
Image	Dexamethasone structure.svg
Caption	Dexamethasone

purpose = assess adrenal gland function | Name = Dexamethasone suppression test | Image = Dexamethasone structure.svg | Caption = Dexamethasone |}}

The dexamethasone suppression test (DST) is used to assess adrenal gland function by measuring how cortisol levels change in response to oral doses or an injection of dexamethasone. It is typically used to diagnose Cushing's syndrome.

The DST was historically used for diagnosing depression, but by 1988 it was considered to be "at best, severely limited in its clinical ability" for this purpose.

Physiology

Dexamethasone is an exogenous steroid that provides negative feedback to the pituitary gland to suppress the secretion of adrenocorticotropic hormone (ACTH). Specifically, dexamethasone binds to glucocorticoid receptors in the anterior pituitary gland, which lie outside the blood–brain barrier, resulting in regulatory modulation.

Test procedures

There are several types of DST procedures:

Overnight DST Two-day DST Intravenous DST Dexamethasone-CRT test

Overnight DST or ONDST - An oral dose of dexamethasone is given between 11pm and midnight, and the cortisol level is measured at 8 - 9am the next morning
Two-day DST - This involves giving an oral dose of dexamethasone at six-hourly intervals for 2 days, with the cortisol level measured 6 hours after the final dose was given
Intravenous DST
Dexamethasone-CRT test

Interpretation

Low-dose and high-dose variations of the test exist. The test is given at low (usually 1–2 mg) and high (8 mg) doses of dexamethasone, and the levels of cortisol are measured to obtain the results.

A low dose of dexamethasone suppresses cortisol in individuals with no pathology in endogenous cortisol production. A high dose of dexamethasone exerts negative feedback on pituitary neoplastic ACTH-producing cells (Cushing's disease), but not on ectopic ACTH-producing cells or adrenal adenoma (Cushing's syndrome).

Dose

A normal result is a decrease in cortisol levels upon administration of low-dose dexamethasone. Results indicative of Cushing's disease involve no change in cortisol on low-dose dexamethasone, but inhibition of cortisol on high-dose dexamethasone. If the cortisol levels are unchanged by low- and high-dose dexamethasone, then other causes of Cushing's syndrome must be considered with further work-up necessary. After the high-dose dexamethasone, it may be possible to make further interpretations.

Cortisol	ACTH†	Interpretation
is not suppressed by low or high doses	Undetectable or low	Primary hypercortisolism is likely; Cushing's syndrome, not disease (i.e., the hypercortisolism is not driven by ACTH hypersecretion)
is not suppressed by low doses, but is suppressed by high doses	Normal to elevated but not in hundreds	Cushing's disease should be considered because the pituitary still retains some feedback control. A pituitary MRI would be needed to confirm.
is not suppressed by high or low doses	Elevated in hundreds	Ectopic ACTH syndrome is likely. If an adrenal tumor is not apparent, a chest CT and abdominal CT is indicated to rule out a different tumor secreting ACTH.

†ACTH as measured prior to dosing of dexamethasone

Equivocal results should be followed by a corticotropin-releasing hormone stimulation test, with inferior petrosal sinus sampling.

References

Theodore C. Friedman, M.D., Ph.D. Professor of Medicine-UCLA Chairman, Department of Internal Medicine Charles R. Drew University (2013).

References

(2020). "Dexamethasone Suppression Test". StatPearls Publishing.
(1988). "How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test.". JAMA.
(February 2000). "Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies". Psychoneuroendocrinology.
(November 2003). "Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome". J. Clin. Endocrinol. Metab..
(2020). "Dexamethasone". StatPearls Publishing.
Kumar, Abbas, Fausto. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Elsevier-Saunders; New York, 2005
(2012). "Harrison's Principles of Internal Medicine". McGraw Hill Medical.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

endocrine-procedures dynamic-endocrine-function-tests

Want to explore this topic further?

Ask Mako anything about Dexamethasone suppression test — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report